Heather Mefford, MD, PhD
Faculty, Department of Cell & Molecular Biology
Heather Mefford, MD, PhD, is a faculty member in the Department of Cell & Molecular Biology at St. Jude.
Stories by Heather Mefford
Importance of citations in scientific research: More than just bragging rights
Being highly cited means your research gets published in high-impact journals and reaches more people.
The agents of discovery: patenting and licensing ideas from bench to bedside
Meet St. Jude’s tech transfer experts who patent and license researchers’ basic science discoveries to help patients worldwide.
For new ideas and collaboration, St. Jude Global hosts neuro-oncology training seminar
St. Jude Global Academy hosted a neuro-oncology seminar to generate new ideas for high-impact interventions and share experiences. Read more.
Ending the HIV epidemic: A national plan to reduce HIV infections
Ending the HIV Epidemic is a bold plan to reduce HIV infections by 90 percent nationally. On a local level, St. Jude aims to have no new HIV cases by 2030.
Smithsonian honors St. Jude visionaries for ‘bubble boy’ cure
Read how St. Jude researchers and clinicians used gene therapy to cure the diabolical bubble boy disease.
Proteins: Playing with molecular rubber duckies
Are you a match? Read how this molecule’s affinity to proteins can change according to water.
New analytical technique reveals the subtle genetic differences among cancer cells
Sequencing data gives insights into what’s going on in a cell. It’s a lot of information. Read how scientists are finding ways to cut through the information and find causes for disease.
Genetic sequencing: How do we put out the fires of genetically driven cancers?
Too much of a good thing? Read how genetic sequencing offers insights into the causes of some cancers, but the avalance of data creates a new set of issues.
Survivorship studies dig in on data
Read how cancer survivorship research reveals more about the late effects of treatment on children – and how the data can paint a more complete picture.
Having those critical conversations about fertility after cancer
As clinicians learn more about the late effects of pediatric cancer treatments, these important discussions with patients are changing.